Page last updated: 2024-12-07

formylmethionyl-leucyl-phenylalanine methyl ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID122066
CHEMBL ID285518
CHEBI ID5158
SCHEMBL ID7614769
MeSH IDM0126542

Synonyms (30)

Synonym
65929-03-5
formylmethionyl-leucyl-phenylalanine methyl ester
fmlp ome
chebi:5158 ,
CHEMBL285518 ,
n-formyl-met-leu-phe methyl ester
methyl n-formyl-l-methionyl-l-leucyl-l-phenylalaninate
methyl (2s)-2-[[(2s)-2-[[(2s)-2-formamido-4-methylsulfanylbutanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoate
l-phenylalanine, n-(n-(n-formyl-l-methionyl)-l-leucyl)-, (sp-4-2)-
hco-met-leu-phe-ome
f-met-leu-phe-ome
formyl-met-leu-phe ome
formyl-methionyl-leucyl-phenylalanine methyl ester
for-met-leu-phe-ome
l-phenylalanine,n-formyl-l-methionyl-l-leucyl-, methyl ester
SCHEMBL7614769
methyl (2s)-2-[[(2s)-2-[[(2s)-2-formamido-4-methylsulfanyl-butanoyl]amino]-4-methyl-pentanoyl]amino]-3-phenyl-propanoate
bdbm50490562
n-formylmethionyl leucyl-phenylalanine methyl ester
(s)-methyl 2-((s)-2-((s)-2-formamido-4-(methylthio)butanamido)-4-methylpentanamido)-3-phenylpropanoate
n-formyl-l-met-l-leu-l-phe-ome
hco-l-met-l-leu-l-phe-ome
n-for-met-leu-phe-ome
formyl-met-leu-phe-ome
f-met-leu-phe-och3
cho-met-leu-phe-ome
n-formyl-met-leu-phe-ome
2-({1-hydroxy-2-[(hydroxymethylidene)amino]-4-(methylsulfanyl)butylidene}amino)-n-(1-methoxy-1-oxo-3-phenylpropan-2-yl)-4-methylpentanimidic acid
DTXSID20984419
Q27106668
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
peptideAmide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another with formal loss of water. The term is usually applied to structures formed from alpha-amino acids, but it includes those derived from any amino carboxylic acid. X = OH, OR, NH2, NHR, etc.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
fMet-Leu-Phe receptorHomo sapiens (human)EC50 (µMol)0.00930.00250.01210.0200AID730962; AID730964
N-formyl peptide receptor 2Homo sapiens (human)EC50 (µMol)0.00930.00250.01250.0190AID730962; AID730964
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-dependent translocase ABCB1Homo sapiens (human)Km100.00000.01403.717210.0000AID681163
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (93)

Processvia Protein(s)Taxonomy
positive regulation of MAPK cascadeSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
response to superoxideSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
ovarian follicle developmentSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
positive regulation of cytokine productionSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
placenta developmentSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
retina homeostasisSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
myeloid cell homeostasisSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
glutathione metabolic processSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
superoxide metabolic processSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
intracellular iron ion homeostasisSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
apoptotic processSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
spermatogenesisSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
embryo implantationSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
sensory perception of soundSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
locomotory behaviorSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
anterograde axonal transportSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
retrograde axonal transportSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
regulation of blood pressureSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
determination of adult lifespanSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
response to heatSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
response to xenobiotic stimulusSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
response to organic substanceSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
gene expressionSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
transmission of nerve impulseSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
neuronal action potentialSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
removal of superoxide radicalsSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
peripheral nervous system myelin maintenanceSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
positive regulation of superoxide anion generationSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
regulation of T cell differentiation in thymusSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
ectopic germ cell programmed cell deathSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
regulation of multicellular organism growthSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
response to hydrogen peroxideSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
superoxide anion generationSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
positive regulation of apoptotic processSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
positive regulation of catalytic activitySuperoxide dismutase [Cu-Zn]Homo sapiens (human)
regulation of GTPase activitySuperoxide dismutase [Cu-Zn]Homo sapiens (human)
negative regulation of neuron apoptotic processSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
response to ethanolSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
negative regulation of cholesterol biosynthetic processSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
regulation of protein kinase activitySuperoxide dismutase [Cu-Zn]Homo sapiens (human)
regulation of organ growthSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
muscle cell cellular homeostasisSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
thymus developmentSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
response to axon injurySuperoxide dismutase [Cu-Zn]Homo sapiens (human)
hydrogen peroxide biosynthetic processSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
negative regulation of inflammatory responseSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
positive regulation of phagocytosisSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
negative regulation of developmental processSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
regulation of mitochondrial membrane potentialSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
heart contractionSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
neurofilament cytoskeleton organizationSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
relaxation of vascular associated smooth muscleSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
auditory receptor cell stereocilium organizationSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
reactive oxygen species metabolic processSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
action potential initiationSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathwaySuperoxide dismutase [Cu-Zn]Homo sapiens (human)
negative regulation of reproductive processSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
G2/M transition of mitotic cell cycleATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic metabolic processATP-dependent translocase ABCB1Homo sapiens (human)
response to xenobiotic stimulusATP-dependent translocase ABCB1Homo sapiens (human)
phospholipid translocationATP-dependent translocase ABCB1Homo sapiens (human)
terpenoid transportATP-dependent translocase ABCB1Homo sapiens (human)
regulation of response to osmotic stressATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
transepithelial transportATP-dependent translocase ABCB1Homo sapiens (human)
stem cell proliferationATP-dependent translocase ABCB1Homo sapiens (human)
ceramide translocationATP-dependent translocase ABCB1Homo sapiens (human)
export across plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
positive regulation of anion channel activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic detoxification by transmembrane export across the plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
regulation of chloride transportATP-dependent translocase ABCB1Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayfMet-Leu-Phe receptorHomo sapiens (human)
chemotaxisfMet-Leu-Phe receptorHomo sapiens (human)
signal transductionfMet-Leu-Phe receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayfMet-Leu-Phe receptorHomo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayfMet-Leu-Phe receptorHomo sapiens (human)
nitric oxide mediated signal transductionfMet-Leu-Phe receptorHomo sapiens (human)
complement receptor mediated signaling pathwayfMet-Leu-Phe receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationfMet-Leu-Phe receptorHomo sapiens (human)
inflammatory responsefMet-Leu-Phe receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayfMet-Leu-Phe receptorHomo sapiens (human)
immune response-regulating cell surface receptor signaling pathwayN-formyl peptide receptor 2Homo sapiens (human)
chemotaxisN-formyl peptide receptor 2Homo sapiens (human)
cell adhesionN-formyl peptide receptor 2Homo sapiens (human)
cell surface receptor signaling pathwayN-formyl peptide receptor 2Homo sapiens (human)
G protein-coupled receptor signaling pathwayN-formyl peptide receptor 2Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayN-formyl peptide receptor 2Homo sapiens (human)
calcium-mediated signalingN-formyl peptide receptor 2Homo sapiens (human)
positive regulation of superoxide anion generationN-formyl peptide receptor 2Homo sapiens (human)
defense response to bacteriumN-formyl peptide receptor 2Homo sapiens (human)
positive regulation of innate immune responseN-formyl peptide receptor 2Homo sapiens (human)
negative regulation of inflammatory responseN-formyl peptide receptor 2Homo sapiens (human)
positive regulation of phagocytosisN-formyl peptide receptor 2Homo sapiens (human)
positive chemotaxisN-formyl peptide receptor 2Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeN-formyl peptide receptor 2Homo sapiens (human)
positive regulation of monocyte chemotaxisN-formyl peptide receptor 2Homo sapiens (human)
cellular response to amyloid-betaN-formyl peptide receptor 2Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayN-formyl peptide receptor 2Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationN-formyl peptide receptor 2Homo sapiens (human)
inflammatory responseN-formyl peptide receptor 2Homo sapiens (human)
complement receptor mediated signaling pathwayN-formyl peptide receptor 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (29)

Processvia Protein(s)Taxonomy
superoxide dismutase activitySuperoxide dismutase [Cu-Zn]Homo sapiens (human)
copper ion bindingSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
protein bindingSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
zinc ion bindingSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
protein phosphatase 2B bindingSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
small GTPase bindingSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
identical protein bindingSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
protein-folding chaperone bindingSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
protein bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATP bindingATP-dependent translocase ABCB1Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
efflux transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ATP hydrolysis activityATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ubiquitin protein ligase bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylcholine floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylethanolamine flippase activityATP-dependent translocase ABCB1Homo sapiens (human)
ceramide floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
G protein-coupled receptor bindingfMet-Leu-Phe receptorHomo sapiens (human)
G protein-coupled receptor activityfMet-Leu-Phe receptorHomo sapiens (human)
N-formyl peptide receptor activityfMet-Leu-Phe receptorHomo sapiens (human)
scavenger receptor bindingfMet-Leu-Phe receptorHomo sapiens (human)
protein bindingfMet-Leu-Phe receptorHomo sapiens (human)
RAGE receptor bindingfMet-Leu-Phe receptorHomo sapiens (human)
complement receptor activityfMet-Leu-Phe receptorHomo sapiens (human)
amyloid-beta bindingN-formyl peptide receptor 2Homo sapiens (human)
G protein-coupled receptor activityN-formyl peptide receptor 2Homo sapiens (human)
scavenger receptor bindingN-formyl peptide receptor 2Homo sapiens (human)
protein bindingN-formyl peptide receptor 2Homo sapiens (human)
signaling receptor activityN-formyl peptide receptor 2Homo sapiens (human)
complement receptor activityN-formyl peptide receptor 2Homo sapiens (human)
N-formyl peptide receptor activityN-formyl peptide receptor 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (26)

Processvia Protein(s)Taxonomy
plasma membraneSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
extracellular regionSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
extracellular spaceSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
nucleusSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
nucleoplasmSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
cytoplasmSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
mitochondrionSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
mitochondrial intermembrane spaceSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
mitochondrial matrixSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
peroxisomeSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
cytosolSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
cytoplasmic vesicleSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
dendrite cytoplasmSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
neuronal cell bodySuperoxide dismutase [Cu-Zn]Homo sapiens (human)
extracellular exosomeSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
axon cytoplasmSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
protein-containing complexSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
peroxisomeSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
mitochondrionSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
nucleusSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
cytosolSuperoxide dismutase [Cu-Zn]Homo sapiens (human)
cytoplasmATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
cell surfaceATP-dependent translocase ABCB1Homo sapiens (human)
membraneATP-dependent translocase ABCB1Homo sapiens (human)
apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
extracellular exosomeATP-dependent translocase ABCB1Homo sapiens (human)
external side of apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
cytoplasmfMet-Leu-Phe receptorHomo sapiens (human)
plasma membranefMet-Leu-Phe receptorHomo sapiens (human)
membranefMet-Leu-Phe receptorHomo sapiens (human)
secretory granule membranefMet-Leu-Phe receptorHomo sapiens (human)
azurophil granule membranefMet-Leu-Phe receptorHomo sapiens (human)
ficolin-1-rich granule membranefMet-Leu-Phe receptorHomo sapiens (human)
plasma membranefMet-Leu-Phe receptorHomo sapiens (human)
cytoplasmN-formyl peptide receptor 2Homo sapiens (human)
plasma membraneN-formyl peptide receptor 2Homo sapiens (human)
membraneN-formyl peptide receptor 2Homo sapiens (human)
specific granule membraneN-formyl peptide receptor 2Homo sapiens (human)
tertiary granule membraneN-formyl peptide receptor 2Homo sapiens (human)
ficolin-1-rich granule membraneN-formyl peptide receptor 2Homo sapiens (human)
plasma membraneN-formyl peptide receptor 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID730964Agonist activity at FPR1/FPR2 receptor in human neutrophils assessed as induction of chemotaxis after 60 mins2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
A formyl peptide substituted with a conformationally constrained phenylalanine residue evokes a selective immune response in human neutrophils.
AID232992Chemotactic index (C.I.) which is the ratio: (migration toward test attractant minus migration toward the buffer)/(migration toward the buffer).2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Biological activity in human neutrophils of di-tripeptides, analogues of the chemotactic fMLP.
AID410785Induction of lysozyme release in human neutrophil at 1 uM2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity.
AID410781Induction of chemotactic activity in human neutrophil assessed as chemotactic index at 1 nM2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity.
AID228018Tested for superoxide anion production towards human neutrophils measured by superoxide dismutase -inhibitable reduction of ferricytochrome c2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Biological activity in human neutrophils of di-tripeptides, analogues of the chemotactic fMLP.
AID472374Activation of cellular function of human neutrophils assessed as chemotactic index at 0.000001 to 10 uM2009European journal of medicinal chemistry, Dec, Volume: 44, Issue:12
Oligomeric formylpeptide activity on human neutrophils.
AID730965Agonist activity at FPR1/FPR2 receptor in human neutrophils assessed as increase in intracellular calcium concentration at 0.1 uM by Fura-2-based spectrofluorophotometric analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
A formyl peptide substituted with a conformationally constrained phenylalanine residue evokes a selective immune response in human neutrophils.
AID410783Induction of superoxide anion radicals production in human neutrophil at 1 uM2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity.
AID730962Agonist activity at FPR1/FPR2 receptor in human neutrophils assessed as induction of superoxide radical generation by spectrophotometric analysis2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
A formyl peptide substituted with a conformationally constrained phenylalanine residue evokes a selective immune response in human neutrophils.
AID102994Release of neutrophil granule enzymes was evaluated by determining lysozyme activity modified for microplate-based assays.2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Biological activity in human neutrophils of di-tripeptides, analogues of the chemotactic fMLP.
AID472370Activation of cellular function of human neutrophils assessed as chemotactic index at 0.01 uM2009European journal of medicinal chemistry, Dec, Volume: 44, Issue:12
Oligomeric formylpeptide activity on human neutrophils.
AID681163TP_TRANSPORTER: ATP hydrolysis in reconstituted proteoliposomes1996The Journal of biological chemistry, Feb-09, Volume: 271, Issue:6
Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.
AID472372Activation of cellular function of cytochalasin B-pretreated human neutrophils assessed as induction of lysozyme release at 1 uM after 15 mins by microplate-based assay2009European journal of medicinal chemistry, Dec, Volume: 44, Issue:12
Oligomeric formylpeptide activity on human neutrophils.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (64)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (12.50)18.7374
1990's10 (15.63)18.2507
2000's39 (60.94)29.6817
2010's7 (10.94)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.52 (24.57)
Research Supply Index4.23 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.49%)5.53%
Reviews1 (1.49%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other65 (97.01%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]